海尔生物

688139.SH

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健设备与用品 > 医疗保健设备

公司聚焦生命科学上游，以创用户最佳体验为目标，业务覆盖低温存储、实验室解决方案、智慧用药、血液技术等领域，为高校科研、医药生物企业、医院、疾控、血站、基层公卫等用户提供数字化场景解决方案，致力于成为全球信赖的生命科学世界级品牌，建设全球引领的一体化生命科学工具与智能生产力平台。公司始终坚持技术领先，推动科技创新，引领产业变革。突破生物医疗低温技术，打破国外垄断，相关研发及产业化水平处于国际领先地位；通过持续研发投入，相继突破多参数高精控制技术、生物大分子等高速离心分离关键技术、高分子材料表面改性技术、高精准识别定位抓取技术、杯式血浆单采技术等核心技术，形成AI、自动化、智能化、材料等4大通用技术平台和制冷、环境控制、分选分离、生物应用等4大垂直技术平台构成的“四横四纵”开放式创新研发体系。在此基础上，公司融合物联网、云计算、人工智能等新兴技术，开创性地推出智慧用血、智慧疫苗接种等数字场景综合解决方案，并继续拓展至智慧实验室、智慧用药等场景，引领产业数智化变革。公司坚持全球化与在地化相结合，持续强化全球业务布局，产品及解决方案已应用于全球160多个国家和地区。在国内市场，覆盖上万家医院、医药生物企业、高校科研机构、疾控、血浆站、检测机构等终端用户。在国际市场，覆盖超800家经销网络，并与世界卫生组织、联合国儿童基金会等近80个国际组织保持长期持续的合作关系；在地化布局快速加强，已在英国、荷兰、美国、新加坡、日本等18个国家建立本地化运营体系，精准服务区域用户的差异化需求。

ESG Score Industry Ranking:
1 / 151 (医疗保健设备与用品)

ESG Rating Distribution(医疗保健设备与用品)

0.66%

AAA

3.31%

15.23%

21.19%

BBB

49.67%

7.95%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.91Updated on 2026-10-29

08.9110

Management & Practices Score：5.93Updated on 2026-09-16

05.937

Controversies Score：2.98Updated on 2026-10-29

02.983

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	8.20	2.78	5.84%
Social	8.84	3.82	65.37%
Governance	7.69	5.86	28.77%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(151 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	688139.SH	海尔生物	AAA	8.91	2.98	5.93	8.20	8.84	7.69
2	002223.SZ	鱼跃医疗	AA	8.44	2.97	5.47	7.99	7.85	7.72
3	300760.SZ	迈瑞医疗	AA	8.41	2.99	5.42	6.67	7.34	8.87
4	300888.SZ	稳健医疗	AA	8.37	3.00	5.38	7.76	7.52	8.03
5	688029.SH	南微医学	AA	8.09	2.99	5.10	6.96	7.48	6.88
6	300298.SZ	三诺生物	AA	7.90	2.98	4.93	5.48	6.97	7.51
7	605369.SH	拱东医疗	A	7.85	2.97	4.88	4.37	7.00	7.42
8	300981.SZ	中红医疗	A	7.77	2.97	4.80	2.82	6.96	7.44
9	300832.SZ	新产业	A	7.75	2.88	4.87	4.67	6.99	7.35
10	0853.HK	微创医疗	A	7.72	2.90	4.82	6.88	7.64	5.17